GNS Healthcare

OverviewSuggest Edit

GNS Healthcare is a big data analytics company advancing and applying industrial-scale data analytics to solve complex care, treatment and cost challenges. It applies causal AI technology that integrates and transforms a variety of patient data types into in silico patients which reveal the complex system of interactions underlying disease progression and drug response. The company aims to accelerate the discovery and development of drugs to improve patient outcomes.
TypePrivate
Founded2000
HQCambridge, MA, US
Websitegnshealthcare.com
Employee Ratings3.1

Latest Updates

Employees (est.) (Apr 2021)81(+3%)
Cybersecurity ratingBMore

Key People/Management at GNS Healthcare

Colin Hill

Colin Hill

CEO and Co-Founder, Director
Jan Berger

Jan Berger

Director
Timothy Thompson

Timothy Thompson

Executive Chair
Bruce Church

Bruce Church

EVP, Research and Early Development
Craig Cimini

Craig Cimini

Director
Rob Coppedge

Rob Coppedge

Director
Show more

GNS Healthcare Office Locations

GNS Healthcare has offices in Cambridge and Somerville
Cambridge, MA, US (HQ)
196 Broadway
Somerville, MA, US
561 Windsor St
Show all (2)

GNS Healthcare Financials and Metrics

Summary Metrics

Founding Date

2000

GNS Healthcare total Funding

$76.1 m

GNS Healthcare latest funding size

$23 m

Time since last funding

2 years ago

GNS Healthcare investors

GNS Healthcare's latest funding round in July 2019 was reported to be $23 m. In total, GNS Healthcare has raised $76.1 m
Show all financial metrics

GNS Healthcare Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

GNS Healthcare Online and Social Media Presence

Embed Graph

GNS Healthcare Company Culture

  • CEO Rating

    F

    30/100

  • Compensation

    F

    10/100

Learn more on Comparably

GNS Healthcare News and Updates

GNS Healthcare inks $23 mln Series D

Cambridge, Massachusetts-based GNS Healthcare, a precision medicine company, has raised $23 million in Series D funding round. Cigna Ventures led the round.

GNS Healthcare Chosen to Present Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology

CAMBRIDGE, Mass., July 2, 2019 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, together with the Alliance for Clinical Trials in Oncology (Alliance), is presenting discoveries of predictive biomarkers for metastatic colorectal cancer (mCRC) patient response to...

Business Health Care Group of Wisconsin Partners with GNS Healthcare to Improve Value of Care Across State

MILWAUKEE and CAMBRIDGE, Mass., May 29, 2019 /PRNewswire/ -- The Business Health Care Group (BHCG), a coalition of employers located in Wisconsin covering 200,000 lives, has partnered with GNS Healthcare (GNS), a leading precision medicine company, to discover best practices of health...

GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018

CAMBRIDGE, Mass., Oct. 22, 2018 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic colorectal cancer this week from their most recent collaboration with the Alliance for Clinical Trials in Oncology (Alliance) at the ESMO 2018...

GNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine's List of Top Female Founders for 2018

CAMBRIDGE, Mass., Oct. 5, 2018 /PRNewswire/ -- Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was profiled as one...

GNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer

CAMBRIDGE, Mass., Oct. 3, 2018 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in the...
Show more

GNS Healthcare Blogs

In Silico in Sight as Biopharma Game-Changer

Pharmaceutical Executive reporter discusses how a coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction. Read the full story here. The post In Silico in Sight as Biopharma Game-Changer appeared first on GNS.

GNS Healthcare Hires Alan Kilyk as Chief Financial Officer

Somerville, MA: GNS Healthcare, an AI company creating in silico patients to simulate disease progression and drug treatment at the individual patient level, is pleased to announce that accomplished finance executive Alan Kilyk has joined the company’s leadership team as Chief Financial Officer effe…

QIAGEN Adopts GNS Healthcare’s Gemini – The in silico Patient™ Across Multiple Cancers

Partnership enables enhanced capability to discover new targets and prognostic markers Somerville, MA: GNS Healthcare, the leading AI-driven precision medicine company, today announced a partnership with QIAGEN, the leading global provider of Sample to Insight solutions for molecular testing. The pa…

Colin Hill to Speak at 2020 STAT Health Tech Summit

This year’s 2020 STAT Health Tech Summit will engage industry leaders, from giants like Apple and Google to upstarts emerging from stealth to discuss how breakthroughs in health and medicine are not just biological – they are technological. The two-day event will include speakers from top executives…

GNS Healthcare Presents Novel Use of AI to Identify Drivers of Response to Immune Checkpoint Inhibitor Therapy

AI-driven in silico patients used to accurately identify types of immune responses in head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC). CAMBRIDGE, Mass.– [July 21, 2020] – GNS Healthcare (GNS), a leading AI and simulation company, presents results that validate th…

GNS Healthcare, MMRF Bring Patient Simulations to Multiple Myeloma Precision Treatment, Trial Design

Precision Oncology News reporter discusses Gemini and its prospective impact on multiple myeloma. Read more here. The post GNS Healthcare, MMRF Bring Patient Simulations to Multiple Myeloma Precision Treatment, Trial Design appeared first on GNS.
Show more

GNS Healthcare Frequently Asked Questions

  • When was GNS Healthcare founded?

    GNS Healthcare was founded in 2000.

  • Who are GNS Healthcare key executives?

    GNS Healthcare's key executives are Colin Hill, Jan Berger and Timothy Thompson.

  • How many employees does GNS Healthcare have?

    GNS Healthcare has 81 employees.

  • Who are GNS Healthcare competitors?

    Competitors of GNS Healthcare include PeraHealth, XP Health and LuminDX.

  • Where is GNS Healthcare headquarters?

    GNS Healthcare headquarters is located at 196 Broadway, Cambridge.

  • Where are GNS Healthcare offices?

    GNS Healthcare has offices in Cambridge and Somerville.

  • How many offices does GNS Healthcare have?

    GNS Healthcare has 2 offices.